Home NDC 0002-7715-63 BASAGLAR
Product NDC 0002-7715
Requested package NDC 0002-7715-63
11-digit product format 000027715
Labeler code 0002
Product ID 0002-7715_3c2283e6-2844-44d2-a447-579b07e77c27
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Insulin glargine
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Eli Lilly and Company
Application BLA205692
Marketing category BLA
Marketing start 2015-12-16
Substance INSULIN GLARGINE
Active strength 100 [iU]/mL
Pharmacologic classes Insulin Analog [EPC], Insulin [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base BASAGLAR
Brand name suffix KwikPen
Listing expiration 2027-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength INSULIN GLARGINE 100 [iU]/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2ZM8CX04RZ Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 847230 Internal RxNorm lookup 1736863 Internal RxNorm lookup 2268064 Internal RxNorm lookup 2268065 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0002-7715-01 BASAGLAR KwikPen 3 mL in 1 SYRINGE INJECTION, SOLUTION 3 34 0002-7715-59 BASAGLAR KwikPen 5 in 1 CARTON INJECTION, SOLUTION 5 34 0002-7715-63 BASAGLAR KwikPen 1 in 1 CARTON INJECTION, SOLUTION 1 34 0002-7715-63 BASAGLAR KwikPen 3 mL in 1 SYRINGE INJECTION, SOLUTION 3 34
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0002-7715 BASAGLAR KWIKPEN (INSULIN GLARGINE) INJECTION, SOLUTION BASAGLAR TEMPO PEN (INSULIN GLARGINE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] 33 Current NDC, Legacy NDC, 4 package rows 20231214_0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 205692 Basaglar insulin glargine 351(a) Disc 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0002-7715-63 00002771563 1 SYRINGE in 1 CARTON (0002-7715-63) / 3 mL in 1 SYRINGE 1 syringe 2016-07-15 0000-00-00 Yes No Current